ELTP
What one share of Elite Pharmaceuticals holds
Pharmaceutical Preparations
Elite Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.12 |
|---|---|
| Profit | $0.04 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | $0.02 |
| Cash and investments | $0.04 |
| Book value | $0.10 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2011 | $0.04 | −$0.14 | $0.00 | $0.01 | — | −$0.10 |
| 2012 | $0.01 | −$0.06 | $0.00 | −$0.00 | — | −$0.05 |
| 2013 | $0.01 | $0.00 | $0.00 | −$0.00 | — | −$0.02 |
| 2014 | $0.01 | −$0.21 | $0.00 | −$0.01 | — | −$0.14 |
| 2015 | $0.01 | −$0.02 | $0.00 | −$0.02 | — | −$0.06 |
| 2016 | $0.02 | −$0.01 | $0.00 | −$0.01 | — | −$0.05 |
| 2017 | $0.01 | −$0.01 | $0.00 | −$0.01 | — | $0.03 |
| 2018 | $0.01 | −$0.01 | $0.00 | −$0.01 | — | $0.01 |
| 2019 | $0.01 | −$0.01 | $0.00 | −$0.01 | — | −$0.00 |
| 2020 | $0.02 | −$0.00 | $0.00 | −$0.00 | — | $0.01 |
| 2021 | $0.03 | $0.00 | $0.00 | $0.00 | — | $0.02 |
| 2022 | $0.03 | $0.01 | $0.00 | $0.01 | — | $0.02 |
| 2023 | $0.03 | $0.00 | $0.01 | −$0.00 | — | $0.03 |
| 2024 | $0.06 | $0.02 | $0.00 | −$0.00 | — | $0.05 |
| 2025 | $0.08 | −$0.00 | $0.00 | $0.01 | — | $0.05 |
| 2026 | $0.13 | $0.03 | $0.00 | $0.02 | — | $0.09 |